January 2025
·
20 Reads
Journal of the Brazilian Chemical Society
This study focused on the synthesis and inhibitory activity of AZT (3’-azido-3’-deoxythymidine) 1,2,3-triazole derivatives against the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), supported by molecular dynamics. The triazoles were synthesized through CuAAC (copper(I)-catalyzed alkyne-azide cycloaddition) with microwave irradiation. Fourier transform infrared spectroscopy (FTIR), 1 H and 13C NMR (nuclear magnetic resonance) and mass analyses confirmed the structures of 3a-3j. A luminescence assay was carried out to evaluate main protease (Mpro) inhibition. Molecular dynamics simulation was performed using GROMACS 2023.2. Ten AZT derivatives were synthesized in good yields of 58.7 to 97.7% and NMR data presented correspondent signals for AZT, such as H-8 at 7.76-7.83 and CH3-9 at 1.77-2.06 as singlets, and H-triazole at 8.03-9.05 as a singlet. Compound 3j revealed low micromolar inhibitory activity with a half-maximal inhibitory concentration (IC50) value of 25.15 µM. The molecular dynamics simulation showed stable binding interactions over a 200 ns simulation with hydrogen bonds involving Arg188, Gln189, and Gln192 residues, which is similar to nirmatrelvir. The drug repurposing and molecular hybridization approach revealed that AZT is a valid option as a skeleton for new SARS-CoV-2 agents.